Arimoclomol eases IBM in small trial
1 January 2014
Arimoclomol showed promise as a treatment for the most common type of inflammatory myopathy in adults over age 50 in a 1-year, phase IIa, "proof-of-concept" study.
Queen Square Centre for Neuromuscular Diseases
Home1 January 2014
Arimoclomol showed promise as a treatment for the most common type of inflammatory myopathy in adults over age 50 in a 1-year, phase IIa, "proof-of-concept" study.